← All trials
NCT04141787
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 11, 2019
- Primary completion
- Jul 31, 2023
- Completion date
- Mar 30, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 310
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vancouver Island Health AuthorityLead sponsor
- Vancouver Island Health AuthorityOverall official - principal investigator
- Vancouver Island Health AuthorityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.